Aveanna Healthcare Holdings, Inc. (AVAH) News
Filter AVAH News Items
AVAH News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
AVAH News Highlights
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
Latest AVAH News From Around the Web
Below are the latest news stories about AVEANNA HEALTHCARE HOLDINGS INC that investors may wish to consider to help them evaluate AVAH as an investment opportunity.
Aveanna price target lowered to $5.25 from $6 at TruistTruist analyst David MacDonald lowered the firm’s price target on Aveanna (AVAH) to $5.25 from $6 and keeps a Hold rating on the shares as part of a broader research note previewing 2025 for Healthcare Services. The firm sees the outlook for the group as “mixed”, with bullish stance on the underlying demand drivers and overarching sector tailwinds that include demographics, value-based care, and core demand being offset by heightened concern around a likely more cost focused government backdrop. |
Aveanna to Participate at the 43rd Annual J.P. Morgan Healthcare ConferenceATLANTA, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that its management team will attend the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco on January 15, 2025. Management will present at 10:30 a.m. PST followed by 1x1 investor meetings on the same day, January 15, 2025. Interested investors and other parties may also listen to a simultaneous webcast of the presentation by logging onto the Investor Relations secti |
Down -17.59% in 4 Weeks, Here's Why You Should You Buy the Dip in Aveanna (AVAH)Aveanna (AVAH) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock. |
Aveanna Healthcare Sees Revenue Growth Despite Net LossThe latest announcement is out from Aveanna Healthcare Holdings ( (AVAH) ). Aveanna Healthcare Holdings reported robust financial growth for Q3 2024, with revenue reaching $509 million, a 6.5% increase from the previous year. The company’s strategic focus on cost reduction and partnerships led to a significant 32.2% rise in adjusted EBITDA, amounting to $47.8 million. Despite a net loss of $42.8 million, Aveanna has raised its full-year 2024 revenue guidance to $2 billion, highlighting their suc |
Aveanna Healthcare Holdings Inc (AVAH) Q3 2024 Earnings Call Highlights: Strong Revenue Growth ...Aveanna Healthcare Holdings Inc (AVAH) reports a 6.5% revenue increase and a 32.2% rise in adjusted EBITDA, while navigating labor market constraints and reimbursement rate challenges. |
Aveanna (AVAH) Reports Q3 Earnings: What Key Metrics Have to SayAlthough the revenue and EPS for Aveanna (AVAH) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. |
Aveanna Healthcare (AVAH) Surpasses Q3 Earnings and Revenue EstimatesAveanna (AVAH) delivered earnings and revenue surprises of 300% and 2.67%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock? |
Aveanna: Q3 Earnings SnapshotATLANTA (AP) — Aveanna Healthcare Holdings Inc. AVAH) on Thursday reported a loss of $42.8 million in its third quarter. On a per-share basis, the Atlanta-based company said it had a loss of 22 cents. |
Aveanna Healthcare Holdings Announces Third Quarter 2024 Financial Results and Revised 2024 OutlookThird Quarter Revenue was $509.0 million, a 6.5% increase over the prior year period Gross margin increased 8.4% to $159.7 million, compared to Q3 2023 Third Quarter Net loss was $42.8 million, compared to net loss of $102.4 million in the comparable prior year period Adjusted Net income was $4.6 million, an increase of $9.3 million over the comparable prior year period Adjusted EBITDA was $47.8 million, a 32.2% increase as compared to the prior year periodFull Year 2024 Revenue guidance raised |
Aveanna Healthcare Holdings Announces Appointment of New DirectorATLANTA, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced the appointment of Brent Layton to serve as a Class III director of the Board of Directors of Aveanna Healthcare Holdings Inc., and additionally as a member of the Audit Committee of the Board, effective November 1, 2024. “I am delighted to announce the appointment of Br |